Nanoparticle-mediated gene delivery: State of the art

Expert Opinion on Biological Therapy

Volumn 4, Issue 8, 2004, Pages 1213-1224

  Ravi Kumar, Mnv ^b   Hellermann, Gary ^a   Lockey, Richard F ^a   Mohapatra, Shyam S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b INSTITUTE OF NANO SCIENCE AND TECHNOLOGY   (India)

Author keywords

Block co polymers; Chitosan; Gene delivery; Lipid; Microparticle; Nanoparticle; PLGA; Polyethylenimines

Indexed keywords

ALGINIC ACID; CHITOSAN; COPOLYMER; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIOLEOYLTRIMETHYLAMMONIUM CHLORIDE; GREEN FLUORESCENT PROTEIN; LIPID; LIPOSOME; NANOPARTICLE; PLASMID VECTOR; POLYETHYLENEIMINE; POLYGLACTIN; POLYLYSINE; POLYVINYL ALCOHOL; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ATOMIC FORCE MICROSCOPY; CELL SPECIFICITY; CHEMICAL MODIFICATION; COLLOID; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; GENE DELIVERY SYSTEM; MICELLE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REVIEW; TISSUE SPECIFICITY;

ANIMALS; CHITOSAN; DNA, RECOMBINANT; DRUG ADMINISTRATION ROUTES; ENDOCYTOSIS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LACTIC ACID; LIPIDS; MICE; MICE, INBRED BALB C; NANOSTRUCTURES; ORGAN SPECIFICITY; POLYETHYLENEIMINE; POLYGLYCOLIC ACID; POLYLYSINE; POLYMERS; SILICON DIOXIDE; TRANSFECTION;

ANIMALIA;

EID: 3442881991     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.4.8.1213     Document Type: Review

References (91)

1. KABANOV V, KABANOV VA: Interpolyelectrolyte and block ionomer complexes for gene delivery: physicochemical aspects. Adv. Drug Del. Rev. (1998) 30:49-60.
2. XIANG ZQ, YANG Y, WILSON JM, ERTL HC: A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology (1996) 219:220-227.
3. KNOWLES MR, HOHNEKER KW, ZHOU Z et al.: A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. (1995) 333:823-831.
4. CHUAH MK, COLLEN D, VANDEN DRIESSCHE T: Biosafety of adenoviral vectors. Curr. Gene Ther. (2003) 3(6):527-543.
5. DE SMEDT SC, DEMEESTER J, HENNINK WE: Cationic polymer based gene delivery systems. Pharm. Res. (2000) 17:113-126. A very good review on the physicochemical and biological properties of polyplexes relevant to gene transfer.
6. GARNETT MC: Gene-delivery systems using cationic polymers. Crit. Rev. Ther. Drug Carrier Syst. (1999) 16:147-207.
7. MINAGAWA K, MATSUZAWA Y, YOSHIKAWA K, MATSUMOTO M, DOI M: Direct observation of the biphasic conformational change of DNA induced by cationic polymers. FEBS Lett. (1991) 295:67-69.
8. KREUTER J, P SPEISER: In vitro studies of poly(methyl methacrylate) adjuvants. J. Pharm. Sci. (1976) 65:1624-1627.
9. COUVREUR P, GRISLAIN L, LENAERT V, BRASSEUR F, GUIOT P, BIERNACKI A: Biodegradable polymeric nanoparticles as drug carrier for antitumor agents. In: Polymeric Nanoparticles and Microparticles, Guiot P, Couvreur P (Eds), CRC Press, Boca Raton, FL (1986):27-93.
10. LABHASETWAR V, SONG C, LEVY RJ: Nanoparticle drug delivery systems for restenosis. Adv. Drug Del. Rev. (1997) 24:63-85.
11. MUZZARELLI RAA: Chitin. Pergamon Press, Oxford, UK (1977).
12. RAVI KUMAR MNV: A review of chitin and chitosan applications. React. Funct. Polym. (2000) 46:1-27.
13. MUMPER RJ, WANG JJ, CLASPELL JM, ROLLAND AP: Novel polymeric condensing carriers for gene delivery. Proc. Int. Symp. Control. Release Bioactive Mater. (1995) 22:178-179.
14. BORCHARD G: Chitosans for gene delivery. Adv. Drug Del. Rev. (2001) 52:145-150
15. MACLAUGHLIN FC, MUMPER RJ, WANG J et al.: Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release (1998) 56:259-272.
16. SATO T, ISHII T, OKAHATA Y: In vitro gene delivery mediated by chitosan, effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials (2001) 22:2075-2080.
17. CUI Z, MUMPER RJ: Chitosan-based nanoparticles for topical genetic immunization. J. Control. Release (2001) 75:409-419.
18. MAO H-Q, ROY K, TRUONG-LE VL, AUGUST JT, LEONG KW: DNA-chitosan nanospheres for gene delivery. Proc. Int. Symp. Control. Rel. Bioact. Mater. Stockholm, Sweden (1997) 24:671-672.
19. LEONG KW, MAO H-Q, TRUONG-LE VL, ROY K, WALSH SM, AUGUST JT: DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Release (1998) 53:183-193.
20. ROY K, MAO H-Q, HUANG SK, LEONG KW: Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. (1999) 5:387-391.
21. KUMAR M, BEHERA AK, LOCKEY AF et al.: Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum. Gene Ther. (2002) 13:1415-1425.
22. ILLUM L, JABBAL-GILL I, HINCHCLIFFE M, FISHER AN, DAVIS SS: Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Del. Rev. (2001) 51:81-96.
23. MAO H-Q, ROY K, JANES KA et al.: Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Release (2001) 70:399-421. An excellent, comprehensive, must-read review on the chitosan-DNA nanoparticle.
24. KOPING-HOGGARD M, GUAN IT, EDWARDS K, NILSSON M, VARUM KM, ARTURSSON P: Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther. (2001) 8:1108-1121.
25. KIM YH, GIHM SH, PARK CR: Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjug. Chem. (2001) 12:932-938.
26. THANOU M, FLOREA BI, GELDOF M, JUN GINGER HE, BORCHARD G: Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials (2002) 23:153-159.
27. PARK YK, PARK HK, SHIN BA et al.: Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier. J. Control. Release (2000) 69:97-108.
28. OKAMOTO H, NISHIDA S, TODO H, SAKAKURA Y, IIDA K, DANJO K: Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process. J. Pharm. Sci. (2003) 92:371-380.
29. KNEUER C, SAMETI M, BAKOWSKY U et al.: A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. Bioconjug. Chem. (2000) 11:926-932.
30. SAHOO SK, PANYAM J, PRABHA S, LABHASETWAR V: Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release (2002) 82:105-115.
31. FELGNER PL, GADEK TR, HOLM M et al.: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA (1987) 84:7413-7417.
32. WASAN EK, FAIRCHILD A, BALAY MB: Cationic liposome-plasmid DNA complexes used for gene transfer retain a significant trapped volume. J. Pharm. Sci. (1998) 87:9-14.
33. MEEKEL AAP, WAGENAAR A, SMISTEROVA J, KROEZE JE: Synthesis of pyridinium amphiphiles used for transfection and some characteristics of amphiphile/DNA complex formation. Eur. J. Org. Chem. (2000) 2000:665-673.
34. PEDROSO DE LIMA M, SIMOES S, PIRES P, FANECA H, DUZGUNES N: Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications. Adv. Drug Deliv. Rev. (2001) 47:277-294. A very good review on the Cationic lipid-DNA complexes and their application to gene delivery.
35. OCHIYA T, TAKAHAMA Y, BABA-TORIYAMA H et al.: Evaluation of cationic liposome suitable for gene transfer into pregnant animals. Biochem. Biophys. Res. Commun. (1999) 258:358-365.
36. ISHIWATA H, SUZUKI N, ANDO S, KIKUCHI H, KITAGAWA T: Characteristics and biodistribution of cationic liposomes and their DNA complexes. J. Control. Release (2000) 69:139-148.
37. OKU N, YAMAZAKI Y, MATSUURA M, SUGIYAMA M, HASEGAWA M, NANGO M: A novel non-viral gene transfer system, polycation liposomes. Adv. Drug Del. Rev. (2001) 52:209-218.
38. WANG CY, HUANG L: pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse. Proc. Natl. Acad. Sci. USA (1987) 84:7851-7855.
39. GAO X, HUANG L: Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry (1996) 53:1027-1036.
40. SORGI FL, BHATTACHARYA S, HUANG L: Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther. (1997) 4:961-968.
41. LI S, RIZZO MA, BHATTACHARYA S, HUANG L: Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther. (1998) 5:930-937.
42. LI S, HUANG L: In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. (1997) 4:891-900.
43. LI S, TSENG WC, STOLZ DB, WU SP, WATKINS SC, HUANG L: Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection. Gene Ther. (1999) 6:585-594.
44. ZHOU X, HUANG L: DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim. Biophys. Acta (1994) 1189:195-203.
45. LIU F, QI H, HUANG L, LIU D: Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther. (1997) 4:517-523.
46. TAN Y, LIU F, LI Z, HUANG L: Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol. Ther. (2001) 3:673-682.
47. LIU F, HUANG L: Development of non-viral vectors for systemic gene delivery. J. Control. Release (2002) 78:259-266. This review discusses gene delivery systems comprising cationic liposome-entrapped polycation-condensed DNA.
48. BARRON LG, MEYER KB, SZOKA FC JR: Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes. Hum. Gene Ther. (1998) 9:315-323.
49. ZELPHATI O, UYECHI LS, BARRON LG, SZOKA FC JR: Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim. Biophys. Acta (1998) 1390:119-133.
50. DAVIS SC, SZOKA FC JR: Cholesterol phosphate derivatives: synthesis and incorporation into a phosphatase and calcium-sensitive triggered release liposome. Bioconjug. Chem. (1998) 9:783-792.
51. LEGENDRE JY, HUANG S-K, SZOKA FC JR: Biochemical, morphological and functional analysis of a cyclic peptide, phospholipid and DNA tenary complex used for gene therapy. J. Liposome Res. (1998) 8:347-366.
52. BARRON LG, UYECHI LS, SZOKA FC JR: Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes. Gene Ther. (1999) 6:1179-1183.
53. XU Y, HUI S-W, FREDERIK P, SZOKA FC JR: Physicochemical characterization and purification of canonic lipoplexes. Biophysical J. (1999) 77:341-353.
54. HIROTA S, TROS DE LLARDUYU C, BARRON L, SZOKA FC JR: Simple mixing device to reproducibly prepare cationic lipid-DNA complexes (lipoplexes). Biotechniques (1999) 27:286-289.
55. BARRON L, GAGNE L, SZOKA FC JR: Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration. Hum. Gene Ther. (1999) 10:1683-1894.
56. NICOL F, NIR S, SZOKA FC JR: Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles. Biophys. J. (2000) 78:818-829.
57. GUO X, SZOKA FC JR: Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester-lipid conjugate. Bioconjug. Chem. (2001) 12:291-300.
58. UYECHI LS, GAGNE L, THURSTON G, SZOKA FC JR: Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components. Gene Ther. (2001) 8:828-836.
59. WAGNER E, PLANK C, ZATLOUKAL K, COTTON M, BIRNSTIEL ML: Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. USA (1992) 89:7934-7938.
60. WOLFERT MA, DASH PR, NAZAROVA O et al.: Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug. Chem. (1999) 10:993-1004.
61. MERDAN T, KUNATH K, FISCHER D, KOPECEK J, KISSEL T: Intracellular processing of poly(ethylene imine)/ ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm. Res. (2002) 19:140-146.
62. POUTON CW, LUCAS P, THOMAS BJ, UDUEHI AN, MILROY DA, MOSS SH: Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J. Control. Release (1998) 53:289-299.
63. PARKER AL, OUPICKY D, DASH PR, SEYMOUR LW: Methodologies for monitoring nanoparticle formation by self-assembly of DNA with poly(L-lysine). Anal. Biochem. (2002) 302:75-80.
64. LEE H, JEONG JH, PARK TG: PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J. Control. Release (2002) 79:283-291.
65. GONZALEZ FERREIRO M, TILLMAN L, HARDEE G, BODMEIER R: Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers. Int. J. Pharm. (2002) 239:47-59.
66. KIRCHEIS R, WIGHTMAN L, WAGNER E: Design and gene delivery activity of modified polyethylenimines. Adv. Drug Del. Rev. (2001) 53:341-358. This is a comprehensive review on porycation PEI as a DNA delivery vehicle.
67. KAZUYOSHI S, KIM SW: A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J. Control. Release (2002) 79:271-281. This report describes cell-specific gene delivery to hepatocytes.
68. RUDOLPH C, SCHILLINGER U, PLANK C et al.: Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimine. Biochim. Biophys. Acta (2002) 1573:75-83.
69. RAVI KUMAR MNV, KUMAR N, DOMB AJ, ARORA M: A review of pharmaceutical polymeric controlled drug delivery systems Adv. Polym. Sci. (2002) 160:1-73.
70. JAIN RA: The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials (2000) 21:2475-2490.
71. GREF R, MINAMITAKE Y, PERACCHIA MT et al.: Biodegradable long-circulating polymeric nanospheres. Science (1994) 263:1600-1603.
72. DAVDA J, LABHASETWAR V: Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. (2002) 233:51-59.
73. PRABHA S, ZHOU W-Z, PANYAM J, LABHASETWAR V: Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm. (2002) 244:105-115.
74. PANYAM J, ZHOU W-Z, PRABHA S, SAHOO SK, LABHASETWAR V: Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J. (2002) 16:1217-1226.
75. KNEUER C, SAMETI M, HALTNER EG et al.: Silica nanoparticles modified with aminosilanes as carriers for plasmid DNA. Int. J. Pharm. (2000) 196:257-261.
76. SAMETI M, BOHR G, RAVI KUMAR MNV et al.: Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. Int. J. Pharm. (2003) 266(1-2):51-60.
77. KATAOKA K, HARADA A, NAGASAKI Y: Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv. Drug Del. Rev. (2001) 47:113-131.
78. HARADA A, KATAOKA K: Formation of polyion complex micelles in aqueous milieu from a pair of oppositely-charged block copolymers with poly (ethylene glycol) segments. Macromolecules (1995) 28:5294-5299.
79. KATAOKA K, TOGAWA H, HARADA A, YASUGI K, MATSUMOTO T, KATAYOSE S: Spontaneous formation of polyion complex micelles with narrow distribution from antisense oligonudeotide and cationic block copolymer in physiological saline. Macromolecules (1996) 29:8556-8557.
80. KATAOKA K, HARADA A, WAKEBAYASHI D, NAGASAKI Y: Polyion complex micelles with reactive aldehyde groups on their surface from plasmid DNA and end-functionalized charged block copolymers. Macromolecules (1999) 32:6892-6894.
81. HARADA A, KATAOKA K: Chain length recognition: core-shell supramolecular assembly from oppositely charged block copolymers. Science (1999) 283:65-67.
82. KAKIZAWA Y, KATAOKA K: Block copolymer micelles for delivery of gene and related compounds. Adv. Drug Del. Rev. (2002) 54:203-222.
83. AKIYAMA Y, HARADA A, NAGASAKI Y, KATAOKA K: Synthesis of poly(ethylene glycol)-block-poly(ethyleneimine) possessing an acetal group at the PEG end. Macromolecules (2000) 33:5841-5845.
84. ALAKHOV VY, MOSKALEVA EY, BATRAKOVA EV, KABANOV AV: Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. Bioconjug. Chem. (1996) 7:209-216.
85. BATRAKOVA EV, LI S, ALAKHOV VY, KABANOV AV: Selective energy depletion and sensitization of multiple drug resistant cancer cells by pluronic block copolymers. Polym. Prep. (2000) 41:1639-1640.
86. LEMIEUX P, GUERIN N, PARADIS G et al.: A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther. (2000) 7:986-991.
87. KABANOV AV, VINOGRADOV SV, SUZDALTSEVA YG, ALAKHOV VY: Water-soluble block polycations as carriers for oligonucleotide delivery. Bioconjug. Chem. (1995) 6:639-643.
88. VINOGRADOV SV, BRONICH TK, KABANOV AV: Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug. Chem. (1998) 9:805-812.
89. KABANOV AV, LEMIEUX P, VINOGRADOV S, ALAKHOV V: Pluronic block copolymers: novel functional molecules for gene therapy. Adv. Drug Del. Rev. (2002) 54:223-233. This is an excellent review on block co-polymers, which discusses the application of these co-polymers both in vitro and in vivo.
90. NETTELBECK DM, JEROME V, MULLER R: Gene therapy: designer promoters for tumour targeting. Trends Genet. (2000) 16:174-181.
91. MERDEN T, KOPECEK J, KISSEL T: Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Del. Rev. (2002) 54:715-758.